perivis

Quarterly results for Bodal Chemicals Ltd

Quarterly Results (Beancounter)August 5, 2026

Company Name: [Not Provided]
Announcement Date: 05 Aug, 2026

Financial Performance (Q1 FY27 – Consolidated, INR Crores)

Unit Conversion: All figures from the latest filing are in ₹ Million.
Conversion: ₹1 Crore = ₹10 Million.

  • Revenue from Operations: ₹709.04 Cr (Q1 FY27)

    • Q4 FY26: ₹588.02 Cr
    • Q1 FY26: ₹454.20 Cr

  • Other Income: ₹6.15 Cr

  • Total Income: ₹715.19 Cr

  • PAT: ₹30.38 Cr

  • EPS (Basic): ₹2.41

No Excise Duty/VAT line item is disclosed in the revenue section. All figures are as reported.

Operating Profit Calculation (Consolidated, Q1 FY27)

All figures in INR Crores (converted from millions):

Key Metrics & Growth

  • Revenue Growth:

    • QoQ: +20.6% (₹709.04 Cr vs ₹588.02 Cr)
    • YoY: +56.1% (₹709.04 Cr vs ₹454.20 Cr)

  • Operating Profit (EBITDA): ₹68.94 Cr

    • QoQ: +213% (from ₹22.0 Cr in Q4 FY26)
    • YoY: +213% (from ₹22.0 Cr in Q1 FY26)
    • Operating Margin: 9.7% (vs 4.5% in Q4 FY26, 4.8% in Q1 FY26)

  • Net Profit (PAT): ₹30.38 Cr

    • QoQ: +>100% (from ₹0.02 Cr in Q4 FY26)
    • YoY: +>100% (from ₹0.95 Cr in Q1 FY26)
    • Net Margin: 4.3% (vs 0.0% in Q4 FY26, 0.2% in Q1 FY26)

  • EPS (Basic): ₹2.41 (vs ₹2.55 in Q4 FY26, ₹0.76 in Q1 FY26)

What’s Different This Quarter

  • Revenue:

    • All-time high at ₹709 Cr, surpassing previous peak of ₹600.5 Cr (Mar 2022).
    • Growth is well above historical Q1 average (₹418 Cr), and recent 4Q average (₹503 Cr).
    • Growth momentum is accelerating: QoQ growth of +20.6% is the highest in the last 8 quarters; YoY growth of +56% is also a record.

  • Margins:

    • Operating margin rebounded to 9.7%, up 520 bps QoQ and 490 bps YoY, reversing the margin compression trend seen over the last year.
    • Net margin also recovered to 4.3% (vs near-zero in recent quarters), highest since Dec 2021.

  • Cost Structure:

    • COGS as % of revenue fell sharply to 60.1% (from 67.7% in Q4 FY26), reflecting improved input cost management or favorable product mix.
    • Employee costs stable at 4.6% of revenue, below historical average (6.4%).
    • Other expenses rose in absolute terms but declined as a % of revenue due to strong topline growth.
    • Finance costs remain elevated but are lower as a % of revenue (2.6% vs 4.0% historical avg).

  • Exceptional/One-off Items:

    • Minimal impact from prior fire loss (₹0.03 Cr in Q1 FY27).
    • Hyperinflation accounting for Turkish subsidiary resulted in a ₹1.31 Cr expense, but this is not material at group level.

  • Taxation:

    • Deferred tax continues to be the main tax expense; prior year adjustments no longer significant this quarter.

Company Updates

  • Auditor’s Review: Clean, unqualified limited review; no issues flagged.
  • Fire Loss: Insurance claim fully settled; no further material impact expected.
  • Incentive Income: ₹2.57 Cr SGST incentive recognized under Punjab Industrial Incentive Scheme.
  • No major capex, M&A, or restructuring disclosed.
  • Segment: Remains a pure-play chemical business.

Historical Context & Competitive Edge

  • Seasonality: Q1 revenue and margin performance are well above historical Q1 averages (revenue: ₹709 Cr vs avg ₹418 Cr; margin: 9.7% vs avg 9.0%).
  • Growth Momentum: Current QoQ and YoY revenue growth rates are the strongest in the available data; marks a clear acceleration from the prior 4Q average (+7.1% QoQ).
  • Margins: Operating margin has rebounded sharply after a year of compression (recent 4Q avg: 6.1%). The 9.7% margin is at the upper end of the historical range.
  • Cost Ratios: COGS as % of revenue improved significantly this quarter (60.1% vs 67.7% prior quarter, and 55.1% recent 4Q avg), suggesting better input cost control or pricing.
  • Record Performance:
    • Revenue: New all-time high.
    • Operating Profit: Near historical peak.
    • PAT: Highest since Dec 2021.

Summary

  • Q1 FY27 marks a decisive turnaround: Revenue, operating profit, and net profit all hit multi-year highs, with margins rebounding sharply after a period of compression.
  • Growth is accelerating: Both sequential and annual growth rates are at record levels.
  • Cost discipline and incentive income contributed to margin recovery.
  • No material one-offs or audit issues. Fire loss impact is now immaterial; insurance claim settled.
  • No new capex or strategic actions disclosed.
  • Outlook: Management commentary is limited, but the results signal a strong start to FY27, with the business operating well above historical norms.

Key Watchpoints:

  • Sustainability of margin recovery and revenue momentum in coming quarters.
  • Any further impact from hyperinflation in Turkish subsidiary (currently not material).

[End of Analysis]

Full Result Extract | Original Filing